July 2026

Every commercial contract negotiation in pharmaceuticals has a clock running in the background. That clock is the patent expiry date,

The first generic filer gets the headlines. The second entrant often gets the margin. In the United States pharmaceutical market,

The pharmaceutical patent system was designed for a different drug. A small molecule, synthesized in a lab, dosed the same

Quick Summary: Traditional pharmaceutical market research tells you what happened yesterday. A patent analyst suite tells you what will happen

A competitor’s pipeline is not a secret. It is a public record, filed in tranches at the USPTO, EPO, and

GW Pharmaceuticals spent roughly two decades and hundreds of millions of dollars turning cannabis extracts into regulated pharmaceuticals. When Jazz

The pharmaceutical industry spent the last decade automating drug discovery. Billions went into generative chemistry platforms, phenomic screening systems, and

The standard Paragraph IV playbook was written for atorvastatin and metformin, not for drugs prescribed to 800 patients nationwide. When

The pharmaceutical vendor ecosystem — CROs, CDMOs, biomarker platform providers, data analytics firms, and laboratory services companies — has spent